Antacid Cherry Flavored
NDC Package 53807-405-12
Package Information
Antacid Cherry Flavored is •shake well before each use•adults and children over 12 years, take 2 - 4 teaspoonsful between meals, at bedtime or as directed by a physician •do not take more than 12 teaspoonfuls in a 24 hour period• do not use the maximum dosage for more than 2 weeks •children under 12 years: ask a doctor. Marketed by Rij Pharmaceutical Corporation, this product is identified by NDC 53807-405 and is authorized under FDA application part332.
Identification & Billing
- RxCUI: 307746 - aluminum hydroxide 200 MG / magnesium hydroxide 200 MG / simethicone 20 MG in 5 mL Oral Suspension
- RxCUI: 307746 - aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension
- RxCUI: 307746 - aluminum hydroxide 1200 MG / milk of magnesia 1200 MG / dimethicone 120 MG per 30 ML Oral Suspension
- RxCUI: 307746 - aluminum hydroxide 200 MG / milk of magnesia 200 MG / dimethicone 20 MG per 5 ML Oral Suspension
- RxCUI: 307746 - aluminum hydroxide 400 MG / milk of magnesia 400 MG / dimethicone 40 MG per 10 ML Oral Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 53807 - Rij Pharmaceutical Corporation
- 53807-405 - Antacid Cherry Flavored
- 53807-405-12 - 355 mL in 1 BOTTLE
- 53807-405 - Antacid Cherry Flavored
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 53807-405-12 identifies a specific commercial package of 355 ml in 1 bottle of Antacid Cherry Flavored, labeled by Rij Pharmaceutical Corporation. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Rij Pharmaceutical Corporation on March 16, 1999. The current certification is valid through December 31, 2019.
How is this Rij Pharmaceutical Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 53807040512. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.